Pazopanib Dr. Reddys 200 mg film-coated tablets EFG
Pazopanib Dr. Reddys 400 mg film-coated tablets EFG
Pazopanib is a type of medicine called a protein kinase inhibitor. It works by preventing the activity of proteins involved in the growth and spread of cancer cells.
Pazopanib is used in adults to treat:
Consult your doctorif you think this may apply to you.
Consult your doctor before starting pazopanib:
Consult your doctorif you think you may have any of these problems. Your doctor will decide if pazopanib is suitable for you. You may need additional teststo check that your kidneys, heart, and liver are working properly.
Pazopanib may increase your blood pressure. Your doctor will check your blood pressure before and while you are taking pazopanib. If you have high blood pressure, you will receive treatment with medicines to help lower it.
Your doctor will tell you to stop taking pazopanib at least 7 days before your operation, as this may affect wound healing. Your treatment will be restarted when the wounds have healed properly.
Pazopanib may make other conditions worse or cause serious side effects. You should be aware of certain symptoms while taking Pazopanib Dr. Reddys to reduce the risk of any problems. See section 4.
Pazopanib is not recommended for people under 18 years of age. It is not known how pazopanib works in this age group. Additionally, it should not be used in children under 2 years of age due to safety concerns.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes herbal medicines and medicines obtained without a prescription.
Some medicines may affect how pazopanib works or increase the chance of you experiencing side effects. Pazopanib may also affect how other medicines work. These include:
Consult your doctor or nurse for more information.
Tell your doctoror pharmacist if you are taking any of these medicines.
Do not take pazopanib with food, as this affects the absorption of the medicine. Take it at least 2 hours after a meal or 1 hour before a meal (see section 3).
Do not drink grapefruit juicewhile being treated with pazopanib, as this may increase the chance of side effects.
Pazopanib is not recommended if you are pregnant.The effect of pazopanib during pregnancy is not known.
Do not breastfeed while taking pazopanib. It is not known if the components of pazopanib pass into breast milk. Inform your doctor of this.
Male patients(including those who have undergone vasectomy) who have partners who are pregnant or may become pregnant (including those using other contraceptive methods) must use condoms during sexual intercourse while taking pazopanib and for at least 2 weeks after the last dose.
Fertility may be affectedby treatment with pazopanib. Consult your doctor about this.
Pazopanib may cause side effects that may affect your ability to drive or use machines.
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet; this is essentially “sodium-free”.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The usual doseis 800 mg taken once a day. The dose can be taken as 2 tablets of 400 mg or as 4 tablets of 200 mg. The dose of 800 mg once a day is the maximum dose per day. Your doctor may need to reduce your dose if you experience side effects.
Do not take pazopanib with food.Take it at least 2 hours after a meal or 1 hour before a meal. For example, you can take it 2 hours after breakfast or 1 hour before lunch. Take pazopanib at the same time every day.
Swallow the tablets whole with water, one after the other. Do not break or crush the tablets, as this affects how the medicine is absorbed and may increase the chance of side effects.
If you take more tablets than you should, ask your doctor or pharmacist for advice.If possible, show them the pack or this leaflet.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested.
Do not take a double dose to make up for forgotten doses. Only take your next dose at the usual time.
Take pazopanib for as long as your doctor recommends. Do not stop treatment unless your doctor advises you to.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Brain inflammation(posterior reversible leukoencephalopathy syndrome).
Rarely, pazopanib can cause brain inflammation, which can be life-threatening. Symptoms include:
Stop taking pazopanib and seek medical attention immediatelyif you experience any of these symptoms or if you have a headache accompanied by any of these symptoms.
Hypertensive crisis(sudden and severe increase in blood pressure)
Pazopanib can cause a sudden and severe increase in blood pressure. This is known as a hypertensive crisis. Your doctor will monitor your blood pressure while you are taking pazopanib. Signs and symptoms of a hypertensive crisis can include:
Stop taking pazopanib and seek medical attention immediatelyif you experience a hypertensive crisis.
The risk of these problems may be greater in people who have a heart condition or are taking other medicines. While you are taking pazopanib, you will be monitored for any heart problems.
Cardiac disorder/heart failure, heart attack
Pazopanib may affect the way your heart pumps or increase the chance of having a heart attack.
Symptoms include:
Seek medical attention immediatelyif you experience any of these symptoms.
Changes in heart rhythm (prolonged QT interval)
Pazopanib may affect your heart rhythm, which in some people can trigger a potentially serious heart condition known as torsades de pointes. This can cause a rapid heartbeat that can lead to loss of consciousness.
Tell your doctorif you notice any unusual change in your heartbeat, such as beats that are too fast or too slow.
Pazopanib may increase the chance of having a stroke. Symptoms of a stroke can include:
Seek medical attention immediatelyif you experience any of these symptoms.
Pazopanib may cause serious bleeding in the digestive system (in the stomach, esophagus, rectum, or intestine), or in the lungs, kidneys, mouth, vagina, or brain, although this is rare. Symptoms include:
Seek medical attention immediatelyif you experience any of these symptoms.
Pazopanib may cause a hole in the stomach or intestine or the formation of an abnormal connection between two parts of the digestive tract (a fistula). Symptoms can include:
Seek medical attention immediatelyif you experience any of these symptoms.
Pazopanib may cause liver problems that can become serious diseases such as liver failure, which can be fatal. Your doctor will monitor your liver enzymes while you are taking pazopanib. Signs that your liver may not be working properly can include:
Seek medical attention immediatelyif you experience any of these symptoms.
Deep vein thrombosis (DVT) and pulmonary embolism
Pazopanib may cause blood clots in the veins, especially in the legs (deep vein thrombosis or DVT), which can move to the lungs (pulmonary embolism). Symptoms can include:
Thrombotic microangiopathy (TMA)
Pazopanib may cause blood clots in the small blood vessels of the kidneys and brain, accompanied by a reduction in red blood cells and cells involved in blood clotting (thrombotic microangiopathy, TMA). Symptoms can include:
Seek medical attention immediatelyif you experience any of these symptoms.
Pazopanib may cause rapid destruction of cancer cells, leading to tumor lysis syndrome, which in some people can be fatal. Symptoms can include irregular heartbeat, seizures, confusion, muscle cramps or spasms, or decreased urine output.
Seek medical attention immediatelyif you experience any of these symptoms.
Infections that occur while taking pazopanib can become serious. Symptoms of infections can include:
Seek medical attention immediatelyif you experience any of these symptoms.
Pazopanib may rarely cause lung inflammation (interstitial lung disease, pneumonitis), which in some people can be fatal. Symptoms include difficulty breathing or cough that does not go away. You will be monitored for any lung problems while taking pazopanib.
Seek medical attention immediatelyif you experience any of these symptoms.
Pazopanib may decrease the amount of thyroid hormone produced in your body. This can cause weight gain and fatigue. Your thyroid hormone levels will be monitored while you are taking pazopanib.
Tell your doctorif you notice significant weight gain or fatigue.
Pazopanib may cause separation or tearing of the back of the eye (retinal detachment or tear). This can lead to blurred vision or changes in vision.
Tell your doctorif you notice any changes in your vision
Possible side effects (including possible serious side effects under the relevant frequency category).
Very Common Side Effects(may affect more than 1 in 10people):
Tell your doctor or pharmacistif any of these side effects become problematic.
Common Side Effects(may affect up to 1 in 10people):
Tell your doctoror pharmacist if any of these side effects become problematic.
Uncommon Side Effects(may affect up to 1 in 100people):
Rare Side Effects(may affect up to 1 in 1,000people):
Frequency Not Known(cannot be estimated from the available data):
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after EXP. The expiry date is the last day of the month indicated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Pazopanib Dr. Reddys
Each Pazopanib Dr. Reddys 200 mg film-coated tablet contains 200 mg of pazopanib.
Each Pazopanib Dr. Reddys 400 mg film-coated tablet contains 400 mg of pazopanib.
The other ingredients of the 200 mg and 400 mg tablets are: magnesium stearate (E 470b), microcrystalline cellulose (E 460), povidone K30 (E 1201), sodium carboxymethyl starch (type A) of potato or maize, microcrystalline cellulose silicified (composed of microcrystalline cellulose and anhydrous colloidal silica), macrogol/polyvinyl alcohol graft copolymer, and polysorbate 80 (E 433).
Pazopanib Dr. Reddys 200 mg film-coated tablets are white to off-white, modified capsule-shaped, film-coated tablets engraved with "2" on one side and smooth on the other. The tablets are approximately 14 x 6 mm in size. They are supplied in blisters of 30, 60, or 90 film-coated tablets or as single-dose blisters of 30 x 1 film-coated tablets.
Pazopanib Dr. Reddys 400 mg film-coated tablets are white to off-white, modified capsule-shaped, film-coated tablets engraved with "4" on one side and smooth on the other. The tablets are approximately 18 x 7 mm in size. They are supplied in blisters of 30, 60, or 90 film-coated tablets or as single-dose blisters of 60 x 1 film-coated tablets.
Not all pack sizes may be marketed.
Reddy Pharma Iberia, S.A.
Avda. Josep Tarradellas nº 38
08029 Barcelona
(Spain)
betapharm Arzneimittel GmbH
Kobelweg 95
86156 Augsburg
Germany
or
Pharmadox Healthcare Ltd
KW20A Kordin Industrial Park
Paola PLA 3000
Malta
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Member State | Medicine Name |
Germany | Pazopanib beta 200 mg Filmtabletten Pazopanib beta 400 mg Filmtabletten |
Spain | Pazopanib Dr. Reddys 200 mg comprimidos recubiertos con película EFG Pazopanib Dr. Reddys 400 mg comprimidos recubiertos con película EFG |
Ireland | Pazopanib Reddy 200 mg film-coated tablets Pazopanib Reddy 400 mg film-coated tablets |
Italy | Pazopanib Dr. Reddy’s 200 mg compresse rivestite con film Pazopanib Dr. Reddy’s 400 mg compresse rivestite con film |
Netherlands | Pazopanib Reddy 200 mg filmomhulde tabletten Pazopanib Reddy 400 mg filmomhulde tabletten |
Poland | Pazopanib Reddy 200 mg tabletki powlekane Pazopanib Reddy 400 mg tabletki powlekane |
Romania | Pazopanib Dr. Reddy’s 200 mg comprimate filmate Pazopanib Dr. Reddy’s 400 mg comprimate filmate |
Date of Last Revision of this Leaflet:January 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.